glp-1 in heart failure Modulatory Role of Receptor Agonists Cardiomyocytes and Increased Risk of Heart Failure

Studies Linking GLP-1 Medications to NAION Several peer-reviewed studies have confirmed an increased risk of NAION in patients taking GLP-1 drugs: Harvard Medical School & Mass General Brigham Study (JAMA Ophthalmology, 2024) 9% of diabetic patients taking semaglutide developed NAION, compared to 1.8% on other diabetes drugs (a 4-fold increased risk)

Erastin has low solubiity and poor metabolic stability and pharmacokinetics, preventing its use in vivo

Reduction in human hair graying by sterubin, an active flavonoid of Eriodictyon angustifolium

Globally, demand for these drugs has surged, particularly in the United States and Europe, where they have become a major part of conversations around obesity treatment

Instead of, like, this healthcare issue being this insidious, never talked about things that slowly crept up and just became ingrained in society to the point where everybody just accepted it